Solventum (NYSE:SOLV) announced today that it completed its previously announced acquisition of Acera Surgical.
ST. LOUIS, June 25, 2025 /PRNewswire/ -- Acera Surgical, a pioneer in synthetic electrospun materials for soft tissue repair, today announced it has received an additional U.S. Food and Drug ...
Zacks Investment Research on MSN
SOLV acquires Acera Surgical to expand advanced wound care portfolio
Solventum SOLV announced the acquisition of Acera Surgical, which specializes in advanced synthetic treatment options for ...
(RTTNews) - Healthcare company Solventum Corp. (SOLV) announced Thursday it has entered into a definitive agreement to acquire Acera Surgical, a privately held bioscience company, for $725 million in ...
Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million ...
ST. LOUIS, July 18, 2022 /PRNewswire/ -- Acera Surgical, Inc. (Acera), a leading bioscience company developing and commercializing a portfolio of fully synthetic materials for regenerative medical ...
Solventum (NYSE: SOLV) announced today it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company focused on developing and commercializing fully engineered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback